Sobi's 2024 Annual and Sustainability Report Highlights
Sobi Unveils Its Comprehensive 2024 Annual and Sustainability Report
Today, Swedish Orphan Biovitrum AB (publ) (Sobi) has proudly presented its Annual and Sustainability Report for the year 2024. This pivotal document encapsulates the significant strides the company has made in its mission to transform the lives of individuals suffering from rare diseases. Sobi continues to be at the forefront of innovation, committed to developing breakthrough treatments that make a meaningful impact.
A Commitment to Sustainability
At the heart of Sobi's operations is a strong commitment to sustainability. The company strives to ensure that everyone who needs its therapies can access approved medications. The 2024 report reflects Sobi's dedication to integrating sustainable practices into its business model, emphasizing responsible management and ethical sourcing.
Enhanced Reporting Standards
The 2024 report includes not only Sobi's audited Annual report but also the comprehensive Sustainability report. This fulfills Sobi's statutory requirements according to the Swedish Annual Accounts Act and adheres to the Global Reporting Initiative (GRI) Standards 2021, drawing inspiration from the latest European Sustainability Reporting Standards (ESRS).
Transitional Framework for Future Compliance
Furthermore, Sobi is actively transitioning to meet the Corporate Sustainability Reporting Directive (CSRD) along with ESRS. This commitment ensures the company aligns with evolving regulatory standards while progressively implementing parts of the fundamental structure in its reporting.
Modifications to Report Structure
The report's layout and content have been carefully modified to meet new requirements, ensuring that Sobi not only complies with legal standards but also upholds its mission to provide transparency and accountability in its documentation.
Accessing Sobi's Annual Report
The full version of Sobi's 2024 Annual and Sustainability Report is now accessible on its official website. The report outlines Sobi's achievements and future goals, showcasing the company’s efforts to drive advancements in healthcare while maintaining a commitment to environmental stewardship. Although the report is available in multiple formats, the Swedish Annual Report published in the European Single Electronic Format (ESEF) is considered the authoritative source in case of discrepancies.
About Sobi
Sobi is renowned as a leading biopharmaceutical company that is committed to improving the lives of those with rare and debilitating diseases. With a workforce of approximately 1,800 employees spread across various regions, including Europe, North America, the Middle East, Asia, and Australia, Sobi maintains a broad reach in delivering innovative therapies. In 2024, Sobi reported significant revenues, amounting to SEK 26 billion, demonstrating the company's robust position within the biopharma market. Notably, Sobi's stock is traded on Nasdaq Stockholm under the ticker STO: SOBI.
Contact Information
For inquiries related to investor relations, Sobi encourages potential investors and interested parties to reach out through the appropriate channels provided on its website. The company is dedicated to fostering open communication and ensuring that all stakeholders are informed of its initiatives and updates.
Frequently Asked Questions
What is the focus of Sobi's 2024 report?
The report emphasizes the progress made in improving access to treatments for rare diseases and sustainability initiatives undertaken throughout the year.
How does Sobi ensure sustainable practices?
Sobi incorporates ethical sourcing, responsible management, and adherence to international standards to ensure sustainability in its operations.
Where can I access the full Annual and Sustainability Report?
The full report can be accessed on Sobi's official website, providing detailed insights into the company's achievements and future goals.
What sets Sobi apart in the biopharmaceutical industry?
Sobi's commitment to rare diseases and innovative medicines sets it apart, alongside its robust sustainability practices and global reach.
How does Sobi measure its sustainability performance?
Sobi utilizes GRI Standards 2021 and complies with new EU regulations to measure and report on its sustainability performance.
About The Author
Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
